Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JULY 8, 2021

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). percent or 16.7

Legalization 75

Legalization Advocacy Legislation Recreational 75

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives.

Marijuana 104

Marijuana Education Advocacy Legislation 104

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Puff Puff Post

FEBRUARY 4, 2019

Kicking any addiction requires discipline, patience and a willingness to follow a treatment plan — something that doesn’t come easily to many young people, experts said. with 1 in 4 high school students reportedly using the products, according to federal data. The state’s underage vaping rate is the highest in the U.S.,

Vaping 101

Vaping Therapy Programs Advocacy 101

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 119

Research and Development Education Agriculture Patients 119

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

MAY 12, 2022

Trisha Cassidy, managing director for Aurora Cannabis in the UK & Ireland, says they are still trying to get into the market further, working on accessibility, advocacy and reimbursement issues through the NHS. “We Aurora is committed to these patients and will continue its dedicated work in the UK.”.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

SpeedWeed

APRIL 6, 2021

The use of cannabis by patients enrolled in a methadone maintenance treatment program is associated with fewer nonfatal opioid overdoses, according to the results of a recently published study. Patients were asked to complete a one-time survey, which included questions about their cannabis use over the past month.

Patients 52

Patients Advocacy Treatment Data 52

Cannabis Law Report

FEBRUARY 28, 2022

Enthea establishes high ‘quality of care’ standards for the treatments offered, including credentialing and managing a network of specialty providers. The two companies believe there is significant potential for these novel treatments to heal and save lives. Our family and company are no strangers to depression and anxiety.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

SEPTEMBER 21, 2021

Publicly available national data indicates that pre-employment marijuana testing disproportionately impacts people of color and acts as a barrier to employment. An update on our advocacy for equitable workplaces. . Here’s the post. positions not regulated by the Department of Transportation).

Policy 52

Policy Advocacy Data Programs 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JANUARY 12, 2022

The product suite includes a purpose-built Companion App for individuals, a Measurement Based Care Platform for providers, and a Real World Data Platform for both academic and commercial researchers. Through the right mix of regulation, technology, and data, both are equally achievable,” says NPA CEO Britt Rollins.

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

SEPTEMBER 9, 2021

The collection of data for the final study was through focused interviews with a snowball sample of eight participants who have experienced trying to enter the cannabis industry in Western City, California. Data were analyzed based on the central question, and three themes emerged. Central Research Question.

Policy 105

Policy Research and Development Collective Banking 105

WeedAdvisor

APRIL 9, 2019

The brick and mortar cannabis store – which enjoyed roaring success when it opened its doors on April 1 st – now faces scrutiny over their treatment of customer IDs. Hunny Pot Assures No Data Collected. . WeedAdvisor is very devoted to consumer advocacy. WeedAdvisor’s Goal to Protect Consumers. .

Collective 40

Collective Advocacy Data Cannabis 40

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

APRIL 12, 2019

We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. Patient advocacy is alive and well in Canada. Medical cannabis patients in Canada have been left alone for far too long; CFAMM is changing that by giving patients an amplified voice.

Access 45

Access Patients Marijuana Medicine 45

Veriheal

JANUARY 11, 2022

Governmental members were initially informed of the Assembly’s request after the national advocacy group published its 2021 “Federal Priorities” document. The data supported the group’s claims with governmental statistics.

Retail 52

Retail Advocacy Business Cannabis 52

The Cannigma

DECEMBER 8, 2021

It’s not with volumes of data, and facts and figures. EG: So, at that time, through your treatment, were you using cannabis? We’re here today with Debbie Churgai, the Executive Director of the Americans for Safe Access, one of the longest standing advocacy organizations around medical cannabis in the United States.

Access 81

Access Policy Patients Cannabis 81

Cannabis Law Report

NOVEMBER 29, 2021

People who have access to harm reduction programs are five times more likely to connect with drug treatment than those who do not and three times more likely to stop problematic drug use. Make data about drug war enforcement publicly available and easily accessible, and regularly publish racial and gender impact analyses.

Policy 52

Policy Decriminalization Treatment History 52

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Despite this, being in possession of a prescription is the only way that cannabis can be legally consumed. EG: The population as well.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

SpeedWeed

APRIL 9, 2021

According to Instagram’s own data, 90% of users follow a business on the platform. Do you provide a white glove treatment or a welcome back old friend experience? According to the data, carousel posts have an average engagement rate per post of 1.92% compared to 1.74% for single images and 1.45% for single videos.

Business 52

Business Cannabis Media Data 52

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). Data collection.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 24, 2022

This statistic is telling of a racial hiring bias when compared to census data that shows 55% of Denver residents are white, while 40% are Black or Hispanic. Another approach is to provide minorities with preferential treatment in licensing.

Legislation 52

Legislation Cannabis Conditions Programs 52

Cannabis Law Report

JUNE 2, 2022

We now have the preliminary data that’s demonstrating native vegetation is sequestering the [cannabis-growing] pesticides into its material at these cultivation sites,” Gabriel explains. Park says that not controlling “mass effluent discharges into municipal wastewater treatment systems,” has been a major regulatory oversight.

Legalization 52

Legalization Cultivation Cannabis Environment 52

Veriheal

AUGUST 31, 2021

The app would also provide data to producers and distributors to identify trends in the market to better serve the needs of consumers. . The design aims to gather and utilize data from the community’s own experiences to improve everyday diversity and discrimination issues in the industry. . Camille Elliott. Major/Program: Nursing.

Research and Development 119

Research and Development Supply Chain Programs Education 119

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Healing Advocacy Fund. Sam is the Executive Director of the Healing Advocacy Fund, which is the nonprofit organization supporting the implementation of Measure 109 in Oregon. in/andrew-chadeayne-989b751/ [link]. Sam Chapman. in/sam-chapman-0a0a8229/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45

Cannabis Law Report

JULY 30, 2019

. “Today, Americans for Safe Access (ASA), the leading advocacy organization dedicated to ensuring safe and legal access to cannabis (marijuana) for therapeutic use and research, and Aurelius Data , Inc.(AD), Green Entrepreneur- Move Aside, CBD: New Data Finds THC Is the Real Medicine in Medical Marijuana. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

NORML

FEBRUARY 18, 2020

The data speaks for itself. No patient should have to worry about losing access to cannabis treatment options. Sign our petition, and make it crystal clear to our representatives that if they support this budget, we will not support them. Thanks for being in the fight with us, NORML.

Marijuana 352

Marijuana DEA Programs Patients 352

NORML

MARCH 26, 2019

Create a Class C misdemeanor charge for small amounts of marijuana IE less than one ounce to facilitate the proper level of non-criminalized accountability and treatment opportunity for personal use amounts. ” – Chief Steve Dye – Grand Prairie Police Department.

Marijuana 262

Marijuana Decriminalization Policy Legislation 262

NORML

JANUARY 28, 2019

It’s understandable lawmakers want reliable data before making a decision. The good news for Kentucky legislators is the data already i s available. We can all agree on objective scientific data. Danny Bentley, R-Russell, erroneously compared cannabis to “snake oil remedies of the 1800s,” according to a WDRB-TV report.

Data 191

Data Clinical Trials Chronic Pain Medicine 191

Veriheal

OCTOBER 28, 2020

Recent polling data in both states indicate warm support, sometimes across party lines. In South Dakota, polling data conducted by Mason-Dixon Polling & Strategy finds that three out of four voters — or 74% of respondents — intend to vote ‘yes’ on Initiative Measure 26. This initiative would legalize cannabis for therapeutic use.

Data 52

Data Chronic Pain Recreational Advocacy 52

Cannabis Law Report

NOVEMBER 20, 2019

Pot Data Co. Cannabis price tracker New Leaf Data Services LLC on Wednesday asked a Connecticut federal court to hit a rival with a default judgment and $4 million in damages for infringing its trademarks and buying up dummy domains to poach users. There’s a lot happening. Latest Updates 21 November 2019. November 15, 2019.

Law 58

Law Vaping Research and Development Legislation 58